Researchers find that some rheumatoid arthritis drugs may reduce Alzheimer’s disease and related dementias in people with cardiovascular disease. Learn more.
DIAGNOSIS VIDEO + ARTICLE: Every 67 seconds, an American develops Alzheimer’s. Half the time, doctors don’t tell. Why would doctors do that? In a key
COMMONLY PRESCRIBED medications for pain and sleep were linked to a rise in harmful side effects in dementia. Check out the latest research.
UNTREATED CONCUSSIONS may trigger CTE dementia (Chronic Traumatic Encephalopathy). Proper evaluation & treatment of concussions help brains heal. Learn how to best manage concussions.
MEDICINES: Alzheimer’s drugs are classified as “Cognitive Enhancers”. Learn why they are NOT for mild memory problems. Find out why prescribing them for Mild Cognitive
MEDICAL VIDEO: Take an active roll in managing Alzheimer’s. Have an open conversation with your doctor. See 5 questions to ask and which answers to
BREAKTHROUGH: FOR THE FIRST TIME in 18 years, the FDA approved a new Alzheimer’s drug. The new medication’s generic name is aducanumab and will be marketed under the brand name Aduhelm. Another first is the drug’s ability to potentially slow down Alzheimer’s, not just cover up its symptoms, as existing medications do. Find out more.
MAYO CLINIC DIAGNOSIS VIDEO + ARTICLE: Hundreds of thousands of people with Hippocampal-Sparing Alzheimer’s go misdiagnosed. With a correct diagnosis, existing medicines can do more.
DIAGNOSIS ARTICLE: The FDA has granted ‘breakthrough device’ designation for a new blood test that can detect Alzheimer’s even before symptoms arise. Learn more.
VIDEO: Researchers are exploring a therapy that involves the use of a surgically implanted device that delivers mild electrical pulses to specific areas of the
DEMENTIA & HOLIDAY PLANS: Relatives with dementia may be frail or have special emotional, mental and physical health needs. Check out these ways to help them enjoy the holiday season.
Three major GLP-1 trials came out in late 2025. One weight-loss drug slowed early Alzheimer’s decline, while two others failed. Surprisingly, this mixed pattern may point the way toward a promising new treatment direction.
New long-term data suggests lecanemab could delay the shift from mild memory loss to moderate Alzheimer’s by up to eight years—offering families precious time and renewed hope.
It is one of the most beautiful Compensations of this life thatNo man can sincerely try to help anotherWithout helping himself.
What are the early symptoms of Alzheimer’s? When to get a professional evaluation.
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
No spam, only news and updates.
